Table 1.
NS/DR | NS | HS | NS/BMT | HS/BMT | |
---|---|---|---|---|---|
CD34+ | 0.05 ± 0.05 | 0.08 ± 0.03 | 0.11 ± 0.03 | 0.05 ± 0.03 | 1.18 ± 0.45*# |
cKit+ | 3.7 ± 0.7 | 3.4 ± 0.5 | 4.4 ± 0.3 | 4.8 ± 0.7 | 5.8 ± 0.7 |
VEGFR2+ | 27.2 ± 4.0 | 26.9 ± 0.6 | 29.6 ± 4.7 | 40.3 ± 1.5*# | 37.3 ± 1.8*# |
p<0.05, vs. NS/DR or NS;
p<0.05, vs. correspondence NS or HS group without BMT therapy. N=4.